Citation Impact
Citing Papers
Preferential Generation of Follicular B Helper T Cells from Foxp3 + T Cells in Gut Peyer's Patches
2009 StandoutScienceNobel
Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program
2007 StandoutNobel
Identification of a Primary Target of Thalidomide Teratogenicity
2010 StandoutScience
Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates γ irradiation–induced thymic lymphoma development
2008
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
Causal effect of health on labor market outcomes : evidence from a random assignment iron supplementation intervention
2013
Inadequate erythropoietin response to anemia: definition and clinical relevance
1994
The DNA-damage response in human biology and disease
2009 StandoutNature
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications
2001
Carbohydrates, Branched-Chain Amino Acids, and Endurances: The Central Fatigue Hypothesis
1995
Mechanisms of type-I- and type-II-interferon-mediated signalling
2005 Standout
Skeletal Muscle Fatigue: Cellular Mechanisms
2008 Standout
Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma
2012
Histamine and Cytokine Therapy: Paper presented at the annual meeting of the Swedish Oncology Society, Stockholm, 1997
1998
Exercise and the Treatment of Clinical Depression in Adults
2002
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
The Treatment of Multiple Myeloma
1994
Effect of infusing branched-chain amino acid during incremental exercise with reduced muscle glycogen content
1994
Multi-input chemical control of protein dimerization for programming graded cellular responses
2019 StandoutNobel
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Structural Plasticity Underpins Promiscuous Binding of the Prosurvival Protein A1
2008
Multiple Myeloma
2004
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
1996 Standout
Monoclonal antibodies: versatile platforms for cancer immunotherapy
2010
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Effect of sustained exercise on plasma amino acid concentrations and on 5‐hydroxytryptamine metabolism in six different brain regions in the rat
1989
Updated Guidelines on the Management of Cytomegalovirus Reactivation in Patients with Chronic Lymphocytic Leukemia Treated with Alemtuzumab
2006
Energy supply and muscle fatigue in humans
1998
Follicular B helper T cells in antibody responses and autoimmunity
2005
Antibody therapy of cancer
2012 Standout
A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells
2014 StandoutNobel
Detection of DNA-Recombinant Human Epoetin-Alfa as a Pharmacological Ergogenic Aid
2002
Death receptors in chemotherapy and cancer
2004
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission – experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)
2004
Effects of acute physical exercise on central serotonergic systems
1997
Apo2L/TRAIL and its death and decoy receptors
2003
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Monoclonal antibodies as therapeutic agents for cancer
2004
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Classification of anticancer drugs—a new system based on therapeutic targets
2003
Thalidomide in multiple myeloma: lack of response of soft‐tissue plasmacytomas
2001
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
2013 Standout
Mammalian Skeletal Muscle Fiber Type Transitions
1997
Interferon-alpha for induction and maintenance in multiple myeloma: Results of two multicenter randomized trials and summary of other studies
1995
Thalidomide
2004
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers
2004
Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab
2012
Drug Insight: thalidomide as a treatment for multiple myeloma
2005
IgG4-related disease
2014 Standout
Iron Biology in Immune Function, Muscle Metabolism and Neuronal Functioning
2001
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
Possible mechanisms of central nervous system fatigue during exercise
1997
Interferons: mechanisms of action and clinical applications
2003
Blood boosting and sport
2000
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
2006 Standout
Thyroid Status and Exercise Tolerance
1995
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Monoclonal antibodies for cancer immunotherapy
2009
Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study.
1994
Anemia of Chronic Disease
2005 Standout
Iron Deficiency and Reduced Work Capacity: A Critical Review of the Research to Determine a Causal Relationship
2001
Metabolic Factors in Fatigue1
1992
Administration of branched-chain amino acids during sustained exercise ? effects on performance and on plasma concentration of some amino acids
1991
Some aspects of the acute phase response after a marathon race, and the effects of glutamine supplementation
1996
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation.
2001
Protective Antitumor Immunity Induced by a Costimulatory Thalidomide Analog in Conjunction with Whole Tumor Cell Vaccination Is Mediated by Increased Th1-Type Immunity
2002
Recent major improvement in long-term survival of younger patients with multiple myeloma
2007
Human variation in skeletal muscle fiber-type proportion and enzyme activities
1989
Luminescent Chemodosimeters for Bioimaging
2012 Standout
Neurobiology of muscle fatigue
1992
Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients
2001
Exceptional Evolutionary Divergence of Human Muscle and Brain Metabolomes Parallels Human Cognitive and Physical Uniqueness
2014 StandoutNobel
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
IL-17 and Th17 Cells
2009 Standout
Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
2003
Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome
2003
Depression and Coronary Heart Disease
2008 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Brown Adipose Tissue: Function and Physiological Significance
2004 Standout
Targeting antiapoptotic A1/Bfl-1 by in vivo RNAi reveals multiple roles in leukocyte development in mice
2012
Spinal and Supraspinal Factors in Human Muscle Fatigue
2001 Standout
Cytokine Storm
2020 Standout
Effect of erythropoietin administration on mammal aerobic power
1991
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Mechanisms limiting glycogen storage in muscle during prolonged insulin stimulation
1988
Effect of recombinant human erythropoietin combined with granulocyte/ macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome
2000
Improved survival in multiple myeloma and the impact of novel therapies
2007 Standout
Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy
2002 Standout
Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma
2008
Physical Activity and Public Health in Older Adults
2007 Standout
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Peptide Ligands for Pro-survival Protein Bfl-1 from Computationally Guided Library Screening
2013
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
The Economic Lives of the Poor
2007 StandoutNobel
Regulatory roles of IL-10–producing human follicular T cells
2019 StandoutNobel
Ingestion of branched‐chain amino acids and tryptophan during sustained exercise in man: failure to affect performance.
1995
Multiple Myeloma
2011 Standout
Patterns of Survival in Multiple Myeloma: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2003
2007
Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies
2016
Running enhances neurogenesis, learning, and long-term potentiation in mice
1999 Standout
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad
2009
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
Works of Fredrik Celsing being referenced
Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).
2001
Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia
2007
Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma
2000
Phase II study of cyclophosphamide, interferon-α and betamethasone (CIB) as induction therapy for patients 60–75 years of age with multiple myeloma stages II and III
2003
High expression of Bfl‐1 contributes to the apoptosis resistant phenotype in B‐cell chronic lymphocytic leukemia
2004
Expression and transcriptional regulation of functionally distinct Bmf isoforms in B-chronic lymphocytic leukemia cells
2003
Histamine and Interleukin-2 in Acute Myelogenous Leukemia
1997
Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D
2001
Changes in plasma concentrations of aromatic and branched‐chain amino acids during sustained exercise in man and their possible role in fatigue
1988
Natural interferon-alpha in combination with melphalan/prednisone versus melphalan/prednisone in the treatment of multiple myeloma stages II and III: a randomized study from the Myeloma Group of Central Sweden
1993
How to calculate human muscle fibre areas in biopsy samples—methodological considerations
1984
Effects of iron deficiency on endurance and muscle enzyme activity in man
1986
Effect of hyperthyroidism on fibre‐type composition, fibre area, glycogen content and enzyme activity in human skeletal muscle
1986
Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)
2002
Prediction of response to treatment with human recombinant erythropoietin in myelodysplastic syndromes.
1993
Effects of anaemia and stepwise‐induced polycythaemia on maximal aerobic power in individuals with high and low haemoglobin concentrations
1987